Cargando…

Effective prediction model for preventing postoperative deep vein thrombosis during bladder cancer treatment

OBJECTIVE: To begin to understand how to prevent deep vein thrombosis (DVT) after an innovative operation termed intracorporeal laparoscopic reconstruction of detenial sigmoid neobladder, we explored the factors that influence DVT following surgery, with the aim of constructing a model for predictin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xing, Xu, Abai, Huang, Jingwen, Shen, Haiyan, Liu, Yazhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753248/
https://www.ncbi.nlm.nih.gov/pubmed/34986677
http://dx.doi.org/10.1177/03000605211067688
_version_ 1784632055518199808
author Liu, Xing
Xu, Abai
Huang, Jingwen
Shen, Haiyan
Liu, Yazhen
author_facet Liu, Xing
Xu, Abai
Huang, Jingwen
Shen, Haiyan
Liu, Yazhen
author_sort Liu, Xing
collection PubMed
description OBJECTIVE: To begin to understand how to prevent deep vein thrombosis (DVT) after an innovative operation termed intracorporeal laparoscopic reconstruction of detenial sigmoid neobladder, we explored the factors that influence DVT following surgery, with the aim of constructing a model for predicting DVT occurrence. METHODS: This retrospective study included 151 bladder cancer patients who underwent intracorporeal laparoscopic reconstruction of detenial sigmoid neobladder. Data describing general clinical characteristics and other common parameters were collected and analyzed. Thereafter, we generated model evaluation curves and finally cross-validated their extrapolations. RESULTS: Age and body mass index were risk factors for DVT, whereas postoperative use of hemostatic agents and postoperative passive muscle massage were significant protective factors. Model evaluation curves showed that the model had high accuracy and little bias. Cross-validation affirmed the accuracy of our model. CONCLUSION: The prediction model constructed herein was highly accurate and had little bias; thus, it can be used to predict the likelihood of developing DVT after surgery.
format Online
Article
Text
id pubmed-8753248
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-87532482022-01-13 Effective prediction model for preventing postoperative deep vein thrombosis during bladder cancer treatment Liu, Xing Xu, Abai Huang, Jingwen Shen, Haiyan Liu, Yazhen J Int Med Res Retrospective Clinical Research Report OBJECTIVE: To begin to understand how to prevent deep vein thrombosis (DVT) after an innovative operation termed intracorporeal laparoscopic reconstruction of detenial sigmoid neobladder, we explored the factors that influence DVT following surgery, with the aim of constructing a model for predicting DVT occurrence. METHODS: This retrospective study included 151 bladder cancer patients who underwent intracorporeal laparoscopic reconstruction of detenial sigmoid neobladder. Data describing general clinical characteristics and other common parameters were collected and analyzed. Thereafter, we generated model evaluation curves and finally cross-validated their extrapolations. RESULTS: Age and body mass index were risk factors for DVT, whereas postoperative use of hemostatic agents and postoperative passive muscle massage were significant protective factors. Model evaluation curves showed that the model had high accuracy and little bias. Cross-validation affirmed the accuracy of our model. CONCLUSION: The prediction model constructed herein was highly accurate and had little bias; thus, it can be used to predict the likelihood of developing DVT after surgery. SAGE Publications 2022-01-06 /pmc/articles/PMC8753248/ /pubmed/34986677 http://dx.doi.org/10.1177/03000605211067688 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Retrospective Clinical Research Report
Liu, Xing
Xu, Abai
Huang, Jingwen
Shen, Haiyan
Liu, Yazhen
Effective prediction model for preventing postoperative deep vein thrombosis during bladder cancer treatment
title Effective prediction model for preventing postoperative deep vein thrombosis during bladder cancer treatment
title_full Effective prediction model for preventing postoperative deep vein thrombosis during bladder cancer treatment
title_fullStr Effective prediction model for preventing postoperative deep vein thrombosis during bladder cancer treatment
title_full_unstemmed Effective prediction model for preventing postoperative deep vein thrombosis during bladder cancer treatment
title_short Effective prediction model for preventing postoperative deep vein thrombosis during bladder cancer treatment
title_sort effective prediction model for preventing postoperative deep vein thrombosis during bladder cancer treatment
topic Retrospective Clinical Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753248/
https://www.ncbi.nlm.nih.gov/pubmed/34986677
http://dx.doi.org/10.1177/03000605211067688
work_keys_str_mv AT liuxing effectivepredictionmodelforpreventingpostoperativedeepveinthrombosisduringbladdercancertreatment
AT xuabai effectivepredictionmodelforpreventingpostoperativedeepveinthrombosisduringbladdercancertreatment
AT huangjingwen effectivepredictionmodelforpreventingpostoperativedeepveinthrombosisduringbladdercancertreatment
AT shenhaiyan effectivepredictionmodelforpreventingpostoperativedeepveinthrombosisduringbladdercancertreatment
AT liuyazhen effectivepredictionmodelforpreventingpostoperativedeepveinthrombosisduringbladdercancertreatment